Doxycycline Inhibition of a Pseudotyped Virus Transduction Does Not Translate to Inhibition of SARS-CoV-2 Infectivity
The rapid spread of the pandemic caused by the SARS-CoV-2 virus has created an unusual situation, with rapid searches for compounds to interfere with the biological processes exploited by the virus. Doxycycline, with its pleiotropic effects, including anti-viral activity, has been proposed as a ther...
Main Authors: | Luisa Diomede, Sara Baroni, Ada De Luigi, Arianna Piotti, Jacopo Lucchetti, Claudia Fracasso, Luca Russo, Valerio Bonaldo, Nicolò Panini, Federica Filippini, Fabio Fiordaliso, Alessandro Corbelli, Marten Beeg, Massimo Pizzato, Francesca Caccuri, Marco Gobbi, Emiliano Biasini, Arnaldo Caruso, Mario Salmona |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/13/9/1745 |
Similar Items
-
In vitro and In vivo Anti-Filarial Effect of Tetracycline/ Doxycycline
by: Subuhi Khan, et al.
Published: (2017-12-01) -
Does oral doxycycline treatment affect eradication of urine vancomycin-resistant ? A tertiary hospital study
by: Yoonjung Kim, et al.
Published: (2020-04-01) -
Doxycycline for the treatment of breast cancer-related lymphedema
by: Stav Brown, et al.
Published: (2022-10-01) -
Metabolic Abnormalities Detected in Phase II Evaluation of Doxycycline in Dogs with Multicentric B-Cell Lymphoma
by: Kelly R. Hume, et al.
Published: (2018-02-01) -
Low-dose doxycycline prevents inflammatory bone resorption in rats
by: M.M. Bezerra, et al.
Published: (2002-05-01)